PROCTER & GAMBLE Co: Form 10-Q for the period ended Mar 31, 2021
Filed with the SEC on Apr 20, 2021 and accepted by EDGAR at Apr 20, 2021, 20:25 ET.
Management's discussion and analysis
As filed, 84,707 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Forward-Looking Statements
Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including, without limitation, the following sections: “Management's Discussion and Analysis,” “Risk Factors,” and "Notes 4 and 10 to the Consolidated Financial Statements." These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law.
Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, currency exchange or pricing controls and localized volatility; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to affect the expected share repurchases and dividend payments; (3) the ability to manage disruptions in credit markets or changes to our credit rating; (4) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to factors outside of our control, such as natural disasters, acts of war or terrorism, or disease outbreaks; (5) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials, and costs of labor, transportation, energy, pension and healthcare; (6) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits and technological advances attained by, and patents granted to, competitors; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third party information and operational technology systems, networks and services, and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage uncertainties related to changing political conditions (including the United Kingdom’s exit from the European Union) and potential implications such as exchange rate fluctuations and market contraction; (13) the ability to successfully manage regulatory and legal requirements and matters (including, without limitation, those laws and regulations involving product liability, product and packaging composition, intellectual property, labor and employment, antitrust, data protection, tax, environmental, and accounting and financial reporting) and to resolve pending matters within current estimates; (14) the ability to manage changes in applicable tax laws and regulations including maintaining our intended tax treatment of divestiture transactions; (15) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; (16) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes, while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited; and (17) the ability to successfully manage the demand, supply, and operational challenges associated with a disease outbreak, including epidemics, pandemics, or similar widespread public health concerns (including the novel coronavirus, COVID-19, outbreak). A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from those projected herein, is included in the section titled "Economic Conditions and Uncertainties" and the section titled "Risk Factors" (Part II, Item 1A) of this Form 10-Q.
The purpose of Management's Discussion and Analysis (MD&A) is to provide an understanding of Procter & Gamble's financial condition, results of operations and cash flows by focusing on changes in certain key measures from year to year. The MD&A is provided as a supplement to, and should be read in conjunction with, our Consolidated Financial Statements and accompanying Notes.
The MD&A is organized in the following sections:
- Overview
- Summary of Results – Nine Months Ended March 31, 2021
- Economic Conditions and Uncertainties
- Results of Operations – Three and Nine Months Ended March 31, 2021
- Business Segment Discussion – Three and Nine Months Ended March 31, 2021
- Liquidity and Capital Resources
- Reconciliation of Measures Not Defined by U.S. GAAP
Throughout the MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net sales and net earnings. We also refer to a number of financial measures that are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP), consisting of organic sales growth, core net earnings per share (Core EPS), adjusted free cash flow and adjusted free cash flow productivity. The explanation at the end of the MD&A provides the definition of these non-GAAP measures, details on the use and the derivation of these measures, as well as reconciliations to the most directly comparable U.S. GAAP measures.
Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share and consumption information. References to market share and market consumption in the MD&A are based on a combination of vendor purchased traditional brick-and-mortar and online data in key markets as well as internal estimates. All market share references represent the percentage of sales of our products in dollar terms on a constant currency basis, relative to all product sales in the category. The Company measures fiscal year to date market shares through the most recent period for which market share data is available, which typically reflects a lag time of one or two months as compared to the end of the reporting period. Management also uses unit volume growth to evaluate and explain drivers of changes in net sales. Organic volume growth reflects year-over-year changes in unit volume excluding the impacts of acquisitions and divestitures and certain one-time items if applicable and is used to explain changes in organic sales.
OVERVIEW
P&G is a global leader in the fast-moving consumer goods industry, focused on providing branded consumer packaged goods of superior quality and value to our consumers around the world. Our products are sold in more than 180 countries and territories, primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, baby stores, specialty beauty stores (including airport duty-free stores), high-frequency stores, pharmacies, electronics stores and professional channels. We also sell direct to consumers. We have on-the-ground operations in approximately 70 countries.
Our market environment is highly competitive with global, regional and local competitors. In many of the markets and industry segments in which we sell our products, we compete against other branded products as well as retailers' private-label brands. Additionally, many of the product segments in which we compete are differentiated by price tiers (referred to as super-premium, premium, mid-tier and value-tier products). We believe we are well positioned in the industry segments and markets in which we operate, often holding a leadership or significant market share position.
The table below provides detail on our reportable segments, including the product categories and brand composition within each segment.
| Reportable Segments | Product Categories (Sub-Categories) | Major Brands |
|---|---|---|
| Beauty | Hair Care (Conditioners, Shampoos, Styling Aids, Treatments) | Head & Shoulders, Herbal Essences, Pantene, Rejoice |
| Skin and Personal Care (Antiperspirants and Deodorants, Personal Cleansing, Skin Care) | Olay, Old Spice, Safeguard, Secret, SK-II | |
| Grooming | Grooming (1) (Shave Care - Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Shave Care; Appliances) | Braun, Gillette, Venus |
| Health Care | Oral Care (Toothbrushes, Toothpastes, Other Oral Care) | Crest, Oral-B |
| Personal Health Care (Gastrointestinal, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Pain Relief, Other Personal Health Care) | Metamucil, Neurobion, Pepto-Bismol, Vicks | |
| Fabric & Home Care | Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents) | Ariel, Downy, Gain, Tide |
| Home Care (Air Care, Dish Care, P&G Professional, Surface Care) | Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer | |
| Baby, Feminine & Family Care | Baby Care (Baby Wipes, Taped Diapers and Pants) | Luvs, Pampers |
| Feminine Care (Adult Incontinence, Feminine Care) | Always, Always Discreet, Tampax | |
| Family Care (Paper Towels, Tissues, Toilet Paper) | Bounty, Charmin, Puffs |
(1) The Grooming product category is comprised of the Shave Care and Appliances operating segments.
The following table provides the percentage of net sales and net earnings by reportable business segment for the three and nine months ended March 31, 2021 (excluding net sales and net earnings in Corporate):
| Three Months Ended March 31, 2021 Net Sales | Net Earnings | Nine Months Ended March 31, 2021 Net Sales | Net Earnings | |
|---|---|---|---|---|
| Beauty | 18% | 19% | 19% | 22% |
| Grooming | 8% | 8% | 9% | 9% |
| Health Care | 13% | 12% | 13% | 13% |
| Fabric & Home Care | 35% | 33% | 34% | 31% |
| Baby, Feminine & Family Care | 26% | 28% | 25% | 25% |
| Total Company | 100% | 100% | 100% | 100% |
SUMMARY OF RESULTS
The following are highlights of results for the nine months ended March 31, 2021 versus the nine months ended March 31, 2020:
- Net sales increased 7% to $57.2 billion, driven by double digit increase in Fabric & Home Care, high single digit increases in Beauty and Health Care, mid-single digits increase in Grooming and low single digits increase in Baby, Feminine & Family Care. Organic sales, which exclude the impacts of acquisitions and divestitures and foreign exchange, also increased 7%. Organic sales increased double digits in Fabric & Home Care, increased high single digits in Health Care, increased mid-single digits in Beauty and Grooming and increased low single digits in Baby, Feminine & Family Care.
- Net earnings were $11.4 billion, an increase of $1.1 billion or 11% versus the prior year period due to the increase in net sales and an increase in operating margins, partially offset by an increase in the effective tax rate and current year charges of $512 million for early debt extinguishment.
- Net earnings attributable to Procter & Gamble increased $1.2 billion or 11% versus the prior year period to $11.4 billion.
- Diluted net earnings per share (EPS) increased 12% to $4.37 due primarily to the increase in net earnings.
- Core net earnings attributable to Procter & Gamble, which represents net earnings excluding charges for the early extinguishment of debt in the current period and incremental restructuring charges in the base period, increased 14% to $11.8 billion. Core net earnings per share increased 14% to $4.53 versus the prior year due primarily to the increase in Core net earnings.
- Operating cash flow was $14.3 billion. Adjusted free cash flow, which is operating cash flow less capital expenditures and certain other impacts, was $12.4 billion. Adjusted free cash flow productivity was 104%.
ECONOMIC CONDITIONS AND UNCERTAINTIES
Global Economic Conditions. Our products are sold in numerous countries across North America, Europe, Latin America, Asia and Africa with more than half our sales generated outside the United States. As such, we are exposed to and impacted by global macro-economic factors, U.S. and foreign government policies and foreign exchange fluctuations. Current global economic conditions are highly volatile due to the COVID-19 pandemic, resulting in both market size contractions in certain countries due to economic slowdowns and government restrictions on movement, as well as market size increases in certain countries due to increased consumption of household cleaning and personal health and hygiene products by consumers. Other macro-economic factors also remain dynamic, and any causes of market size contraction, such as reduced GDP in commodity-dependent economies, greater political unrest or instability in the Middle East, Central & Eastern Europe, certain Latin American markets, the Hong Kong market in Greater China and the Korean peninsula could reduce our net sales or erode our operating margin, in either case reducing our net earnings and cash flows.
Changes in Costs. Our costs are subject to fluctuations, particularly due to changes in commodity prices, transportation costs and our own productivity efforts. We have significant exposures to certain commodities, in particular, certain oil-derived materials like resins and paper-based materials like pulp, and volatility in the market price of these commodity input materials has a direct impact on our costs. Disruptions in our manufacturing, supply and distribution operations due to the COVID-19 pandemic may also impact our costs. If we are unable to manage these impacts through pricing actions, cost savings projects and sourcing decisions, as well as through consistent productivity improvements, it may adversely impact our gross margin, operating margin, net earnings and cash flows. Net sales could also be adversely impacted following pricing actions if there is a negative impact on consumption of our products. We strive to implement, achieve and sustain cost improvement plans, including outsourcing projects, supply chain optimization and general overhead and workforce optimization. In fiscal 2017, we communicated specific elements of a multi-year cost reduction program which has resulted in targeted enrollment reductions and other savings. If we are not successful in executing and sustaining these changes, there could be a negative impact on our gross margin, operating margin, net earnings and cash flows.
Foreign Exchange. We have both translation and transaction exposure to the fluctuation of exchange rates. Translation exposures relate to exchange rate impacts of measuring income statements of foreign subsidiaries that do not use the U.S. dollar as their functional currency. Transaction exposures relate to 1) the impact from input costs that are denominated in a currency other than the local reporting currency and 2) the revaluation of transaction-related working capital balances denominated in currencies other than the functional currency. In the past two fiscal years, as well as the current fiscal year, the U.S. dollar has strengthened versus a number of foreign currencies, leading to lower sales and earnings from these foreign exchange impacts. Certain countries experiencing significant exchange rate fluctuations, like Argentina, Brazil, Russia, Turkey, the United Kingdom, China as well as the European Union have previously had, and could in the future have, a significant impact on our net sales, costs and net earnings. Increased pricing in response to certain fluctuations in foreign currency exchange rates may offset portions of the currency impacts but could also have a negative impact on consumption of our products, which would affect our net sales, gross margin, operating margin, net earnings and cash flows.
Government Policies. Our net earnings and cash flows could be materially affected by changes in U.S. or foreign government legislative, regulatory or enforcement policies. For example, any future tax regulatory guidance issued as a result of the Tax Cuts and Jobs Act enacted in December 2017 (the U.S. Tax Act) or other changes in U.S. tax policies, or any significant change in global tax policy adopted under the current work being led by the OECD for the G20 focused on "Addressing the Challenges of the Digitalization of the Economy." The breadth of the OECD project extends beyond pure digital businesses and is likely to impact all multinational businesses by redefining jurisdictional taxation rights. Further, our net sales, gross margin, operating margin, net earnings and cash flows may be impacted by changes in U.S. and foreign government policies related to environmental and climate change matters. Additionally, we attempt to carefully manage our debt, currency and other exposures in certain countries with currency exchange, import authorization and pricing controls, such as Nigeria, Algeria, Egypt, Argentina and Turkey. Further, our net sales, gross margin, operating margin, net earnings and cash flows could be affected by changes to international trade agreements in North America and elsewhere, including increases of import tariffs, both currently effective and future potential changes. Changes in government policies in these areas might cause an increase or decrease in our net sales, gross margin, operating margin, net earnings and cash flows.
COVID-19 Pandemic Disclosures. Our net sales, net earnings and cash flows may be impacted by U.S. and foreign government policies to manage the COVID-19 pandemic, such as movement restrictions or site closures. The Company’s priorities during the COVID-19 pandemic continue to be protecting the health and safety of our employees; maximizing the availability of products that help consumers with their health, hygiene and cleaning needs; and, using our employees’ talents and our resources to help society meet and overcome the current challenges. Because the Company sells products that are essential to the daily lives of consumers, the COVID-19 pandemic has not had a materially negative impact to our consolidated net sales, gross margin, operating margin, net earnings and cash flows. The pandemic has had both positive and negative impacts to our net sales and net earnings during the three and nine month periods ended March 31, 2021. We have experienced
a significant increase in demand and consumption of certain of our product categories (fabric, home cleaning and hygiene products) primarily in North America, caused in part by changing consumer habits, pantry stocking and retailer inventory replenishment, due to the COVID-19 pandemic, contributing to increases in net sales, net earnings and cash flows. At the same time, we experienced a decrease in net sales due to the economic slowdown and restricted consumer movements in certain regions, including IMEA (India, Middle East and Africa) and Asia Pacific, in certain channels, including travel retail and professional, and in certain of our beauty and grooming products. In the future, the pandemic may cause reduced demand for our products if it results in a recessionary global economic environment. Demand in certain countries in Latin America, Asia Pacific, and IMEA may be particularly susceptible to recession. It could also lead to volatility in consumer access to our products due to government actions impacting our ability to produce and ship products or impacting consumers’ movements and access to our products. We believe that over the long term, there will continue to be strong demand for categories in which we operate, particularly our products that deliver essential health, hygiene and cleaning benefits. However, the timing and extent of demand recovery in certain markets in Asia Pacific, IMEA and Latin America, the resumption of international travel, the timing and impact of potential consumer pantry destocking in markets including North America and Europe, and product demand volatility caused by future economic trends are unclear. Accordingly, there may be heightened volatility in net sales, net earnings and cash flows during and subsequent to the duration of the pandemic. Our retail customers are also being impacted by the pandemic. Their success in addressing the issues and maintaining their operations could impact consumer access to, and as a result, sales of our products.
Our ability to continue to operate without any significant negative impacts will in part depend on our ability to protect our employees and our supply chain. The Company has endeavored to follow actions recommended by governments and health authorities, including on vaccine administration, to protect our employees world-wide, with particular measures in place for those working in our plants and distribution facilities. We have also worked closely with local and national officials to keep our manufacturing facilities open due to the essential nature of the majority of our products. While we have been able to broadly maintain our operations, we experienced some disruption in our supply chain in certain markets in Asia Pacific and IMEA in the first months of the pandemic due primarily to the restriction of employee movements as well as increased transportation and manufacturing costs. We intend to continue to work with government authorities and implement our employee safety measures to ensure that we continue manufacturing and distributing our products during the pandemic. However, uncertainty resulting from the pandemic could result in an unforeseen disruption to our supply chain (for example, a closure of a key manufacturing or distribution facility or the inability of a key material or transportation supplier to source and transport materials) that could impact our operations.
Because the pandemic has not had a material negative impact on our operations or demand for our products and resulting net sales and net earnings, it has also not negatively impacted the Company’s liquidity position. We continue to generate operating cash flows to meet our short-term liquidity needs, and we have maintained access to the capital markets enabled by our strong short- and long-term credit ratings. We have also not observed any material impairments of our assets or a significant change in the fair value of assets due to the COVID-19 pandemic.
For additional information on risk factors that could impact our results, please refer to “Risk Factors” in Part I, Item 1A of the Company's Form 10-K/A for the fiscal year ended June 30, 2020.
RESULTS OF OPERATIONS – Three Months Ended March 31, 2021
The following discussion provides a review of results for the three months ended March 31, 2021 versus the three months ended March 31, 2020.
Amounts in millions, except per share amounts
| Three Months Ended March 31 2021 | 2020 | % Chg | |
|---|---|---|---|
| Net sales | $18,109 | $17,214 | 5% |
| Operating income | 3,785 | 3,453 | 10% |
| Net earnings | 3,249 | 2,957 | 10% |
| Net earnings attributable to Procter & Gamble | 3,269 | 2,917 | 12% |
| Diluted net earnings per common share | 1.26 | 1.12 | 13% |
| Core net earnings per common share | 1.26 | 1.17 | 8% |
| Three Months Ended March 31 | |||
| COMPARISONS AS A PERCENTAGE OF NET SALES | 2021 | 2020 | Basis Pt Chg |
| Gross margin | 50.7% | 49.4% | 130 |
| Selling, general & administrative expense | 29.8% | 29.3% | 50 |
| Operating income | 20.9% | 20.1% | 80 |
| Earnings before income taxes | 21.4% | 20.3% | 110 |
| Net earnings | 17.9% | 17.2% | 70 |
| Net earnings attributable to Procter & Gamble | 18.1% | 16.9% | 120 |
Net Sales
Net sales for the quarter increased 5% to $18.1 billion while unit volume was unchanged. Increased pricing had a 2% positive impact to net sales. Mix had a 2% positive impact to net sales, driven by the disproportionate growth of the North America region, the Home Care, Appliances and Oral Care businesses, and super premium products within Skin and Personal Care, all of which have higher than company-average selling prices. Favorable foreign exchange had a 1% positive impact on net sales. Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 4% while organic volume was unchanged. Net sales increased high single digits in Beauty and Fabric & Home Care, increased mid-single digits in Grooming and Health Care and was unchanged in Baby, Feminine & Family Care. On a regional basis, volume increased double digits in Greater China and increased low single digits in North America and IMEA, partially offset by a mid-single digits decrease in Europe and a low single digit decrease in Asia Pacific. Volume was unchanged in Latin America.
| Net Sales Change Drivers 2021 vs. 2020 (Three Months Ended March 31) (1) Volume with Acquisitions & Divestitures | Volume Excluding Acquisitions & Divestitures | Foreign Exchange | Price | Mix | Other (2) | Net Sales Growth | |
|---|---|---|---|---|---|---|---|
| Beauty | 2% | 2% | 2% | 2% | 3% | —% | 9% |
| Grooming | —% | —% | —% | 2% | 2% | —% | 4% |
| Health Care | —% | —% | 1% | —% | 3% | —% | 4% |
| Fabric & Home Care | 3% | 3% | 1% | 2% | 2% | —% | 8% |
| Baby, Feminine & Family Care | (4)% | (4)% | 1% | 2% | 1% | —% | —% |
| Total Company | —% | —% | 1% | 2% | 2% | —% | 5% |
(1) Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.
(2) Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.
Operating Costs
Gross margin increased 130 basis points to 50.7% of net sales for the quarter. Gross margin benefited from:
- 120 basis points of gross manufacturing cost savings projects (90 basis points net of product and packaging reinvestments),
- 80 basis points of help from higher pricing, and
- 100 basis points of help due to lower restructuring costs versus the base period
These benefits were partially offset by a 60 basis point decline from unfavorable mix (due to the disproportionate growth of the Home Care and Appliances categories which have lower than company-average margins) and other impacts, a 50 basis-point decline from unfavorable foreign exchange and a 30 basis-point decline due to higher commodity costs.
Total SG&A spending increased 7% to $5.4 billion due to increases in both marketing spending and overhead costs. SG&A as a percentage of net sales increased 50 basis points to 29.8% due to an increase in marketing spending and overhead costs as a percentage of net sales. Marketing spending as a percentage of net sales increased 50 basis points due to investments in media, partially offset by the positive scale impacts of the net sales increase and savings in agency compensation, production costs and advertising spending. Overhead costs as a percentage of net sales increased 20 basis points primarily due to inflation and other cost increases and higher restructuring charges versus the base period, partially offset by the positive scale impacts of the net sales increase and productivity savings. Other net operating costs as a percentage of net sales decreased 30 basis points due to a reduction in foreign exchange transactional charges. Productivity-driven cost savings delivered 90 basis points of benefit to SG&A as a percentage of net sales.
Non-Operating Expenses and Income
Interest expense was $106 million for the quarter, a nominal increase versus the prior year period. Interest income was $11 million for the quarter, a $28 million decrease versus the prior year period due to lower U.S. interest rates. Other non-operating income was $187 million, an increase of $81 million primarily due to an unrealized gain on an equity investment that became publicly traded in the current period.
Income Taxes
For the three months ended March 31, 2021, the effective tax rate increased 70 basis points versus the prior year period to 16.2% due to:
- a 100 basis-point increase from lower excess tax benefits of share-based compensation (180 basis-point reduction in the current period versus 280 basis-point reduction in the prior year period),
- a 150 basis-point increase related to the prior year tax benefit arising from transactions to simplify our legal entity structure, and
- a 10 basis-point increase from unfavorable impacts from the geographic mix of current year earnings.
These increases are partially offset by:
- a 155 basis-point decrease from higher current period deductions for foreign-derived intangible income, and
- a 35 basis-point decrease from discrete impacts related to uncertain tax positions (65 basis-point favorable impact in the current year versus a 30 basis-point favorable impact in the prior year period).
Net Earnings
Operating income increased $332 million, or 10%, to $3.8 billion for the quarter, due to the net sales increase and the increase in gross margin, partially offset by the increase in SG&A as a percentage of sales, all of which are described above. Net earnings increased $292 million, or 10%, to $3.2 billion as the increases in operating income and other non-operating income discussed above were partially offset by the increase in income taxes. Foreign exchange had a nominally positive impact on net earnings for the quarter, including both transactional charges and translational impacts from converting earnings from foreign subsidiaries to U.S. dollars. Net earnings attributable to Procter & Gamble increased $352 million, or 12%, to $3.3 billion for the quarter. Diluted net earnings per share increased 13% to $1.26 versus the base period due to the increase in net earnings and a reduction in the weighted average number of shares outstanding. Diluted net EPS increased 8% versus the base period Core EPS which represents diluted net earnings per share excluding incremental restructuring charges in the base period related to our productivity and cost savings plans.
RESULTS OF OPERATIONS – Nine Months Ended March 31, 2021
The following discussion provides a review of results for the nine months ended March 31, 2021 versus the nine months ended March 31, 2020.
Amounts in millions, except per share amounts
| Nine Months Ended March 31 2021 | 2020 | % Chg | |
|---|---|---|---|
| Net sales | $57,172 | $53,252 | 7% |
| Operating income | 14,446 | 12,225 | 18% |
| Net earnings | 11,444 | 10,317 | 11% |
| Net earnings attributable to Procter & Gamble | 11,400 | 10,227 | 11% |
| Diluted net earnings per common share | 4.37 | 3.89 | 12% |
| Core net earnings per common share | 4.53 | 3.96 | 14% |
| Nine Months Ended March 31 | |||
| COMPARISONS AS A PERCENTAGE OF NET SALES | 2021 | 2020 | Basis Pt Chg |
| Gross margin | 52.2% | 50.6% | 160 |
| Selling, general & administrative expense | 27.0% | 27.6% | (60) |
| Operating income | 25.3% | 23.0% | 230 |
| Earnings before income taxes | 24.6% | 23.2% | 140 |
| Net earnings | 20.0% | 19.4% | 60 |
| Net earnings attributable to Procter & Gamble | 19.9% | 19.2% | 70 |
Net Sales
Net sales for the nine months ended March 31, 2021 increased 7% to $57.2 billion on a 4% increase in unit volume. Increased pricing had a 1% positive impact to net sales. Mix had a 2% positive impact to net sales driven by the disproportionate growth of the North America region and the Home Care and Appliances categories, all of which have higher than company-average selling prices. Foreign exchange had no net impact on net sales. Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales also increased 7% on a 4% increase in organic volume. Net sales increased double digits in Fabric & Home Care, increased high single digits in Beauty and Health Care, increased mid-single digits in Grooming and increased low single digits in Baby, Feminine & Family Care. On a regional basis, volume increased high single digits in North America and in Greater China driven by innovation and increased demand, particularly in household cleaning and personal hygiene products due in part to the COVID-19 pandemic. Volume increased low single digits in Latin America and IMEA, partially offset by a low single digits decrease in Asia Pacific. Volume was unchanged in Europe.
| Net Sales Change Drivers 2021 vs. 2020 (Nine Months Ended March 31) (1) Volume with Acquisitions & Divestitures | Volume Excluding Acquisitions & Divestitures | Foreign Exchange | Price | Mix | Other (2) | Net Sales Growth | |
|---|---|---|---|---|---|---|---|
| Beauty | 4% | 4% | —% | 2% | 1% | —% | 7% |
| Grooming | 3% | 3% | (1)% | 2% | 1% | —% | 5% |
| Health Care | 4% | 4% | —% | 1% | 3% | —% | 8% |
| Fabric & Home Care | 7% | 7% | —% | 1% | 3% | —% | 11% |
| Baby, Feminine & Family Care | 1% | 1% | —% | 1% | 1% | —% | 3% |
| Total Company | 4% | 4% | —% | 1% | 2% | —% | 7% |
(1) Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.
(2) Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.
Operating Costs
Gross margin increased 160 basis points to 52.2% of net sales for the fiscal year to date period. Gross margin benefited from:
- 140 basis points of gross manufacturing cost savings projects (120 basis points net of product and packaging reinvestments),
- 60 basis points of help from higher pricing,
- 50 basis points of help due to lower restructuring costs versus the base period, and
- 20 basis points of lower commodity costs
These benefits were partially offset by a 50 basis-point decline from unfavorable foreign exchange and a 40 basis point decline from unfavorable mix (due to the disproportionate growth of Home Care and Appliances categories which have lower than company-average margins, as well as mix within segments due to the growth of lower margin product forms and large sizes in certain categories) and other impacts.
Total SG&A spending increased 5% to $15.4 billion primarily due to increases in both marketing spending and overhead costs. SG&A as a percentage of net sales decreased 60 basis points to 27% primarily due to a reduction in overhead costs as a percentage of net sales. Marketing spending as a percentage of net sales was unchanged as the positive scale impacts of the net sales increase and savings in agency compensation, production costs and advertising spending, were offset by reinvestments in media. Overhead costs as a percentage of net sales declined 40 basis points due to the positive scale impacts of the net sales increase and productivity savings, partially offset by higher restructuring costs versus the base period, inflation and other cost increases. Other net operating costs as a percentage of net sales decreased 20 basis points due to a reduction in foreign exchange transactional charges. Productivity-driven cost savings delivered 100 basis points of benefit to SG&A as a percentage of net sales.
Non-Operating Expenses and Income
Interest expense was $385 million for the fiscal year to date, an increase of $77 million versus the prior year period due to higher average interest rates driven by a higher proportion of fixed rate debt. Interest income was $30 million for the fiscal year to date, a $103 million decrease versus the prior year period due to lower U.S. interest rates. Other non-operating expense was $40 million, a change of $363 million versus the prior year non-operating income of $323 million, primarily due to current period charges of $512 million for early debt extinguishment ($427 million after tax), partially offset by an unrealized gain on an equity investment that became publicly traded in the current period and an increase in net non-operating benefits on defined benefit retirement plans caused by annual updates to actuarial assumptions.
Income Taxes
For the nine months ended March 31, 2021, the effective tax rate increased 200 basis points versus the prior year period to 18.6% due to:
- a 70 basis-point increase from unfavorable impacts from the geographic mix of current year earnings, caused primarily by disproportionately higher sales and earnings in the U.S.,
- a 130 basis-point increase related to the prior year tax benefit arising from transactions to simplify our legal entity structure,
- a 10 basis-point increase from the impact of the early extinguishment of debt in the current year, and
- a 10 basis-point increase from lower excess tax benefits of share-based compensation (170 basis-point reduction in the current period versus 180 basis-point reduction in the prior year period).
These increases are partially offset by:
- a 10 basis-point decrease from the higher current period deduction for foreign-derived intangible income, and
- a 10 basis-point decrease from discrete impacts related to uncertain tax positions (25 basis-point favorable impact in the current year versus a 15 basis-point favorable impact in the prior year period).
Net Earnings
Operating income increased $2.2 billion, or 18%, to $14.4 billion for the nine months ended March 31, 2021, due to the net sales increase, the increase in gross margin and the decrease in SG&A as a percentage of sales, all of which are described above. Net earnings increased $1.1 billion, or 11%, to $11.4 billion for the fiscal year to date period primarily due to the increase in operating income, partially offset by the increase in other non-operating expense (driven by the early debt extinguishment charge) and the increase in the effective tax rate. Foreign exchange had a negative impact of approximately $168 million on net earnings for the fiscal year to date period, including both transactional charges and translational impacts from converting earnings from foreign subsidiaries to U.S. dollars. Net earnings attributable to Procter & Gamble increased $1.2 billion, or 11%, to $11.4 billion for the fiscal year to date period. Diluted net earnings per share increased 12% to $4.37. Core net earnings per share increased 14% to $4.53. Core EPS represents diluted net earnings per share excluding current period charges for the early extinguishment of debt and incremental restructuring charges in the base period related to our productivity and cost savings plans.
BUSINESS SEGMENT DISCUSSION – Three and Nine Months Ended March 31, 2021
The following discussion provides a review of results by reportable business segment. Analysis of the results for the three- and nine month-periods ended March 31, 2021 is provided based on a comparison to the same three- and nine-month periods ended March 31, 2020. The primary financial measures used to evaluate segment performance are net sales and net earnings. The table below provides supplemental information on net sales, earnings before income taxes and net earnings by reportable business segment for the three and nine months ended March 31, 2021 versus the comparable prior year period (dollar amounts in millions):
| Three Months Ended March 31, 2021 Net Sales | % Change Versus Year Ago | Earnings/(Loss) Before Income Taxes | % Change Versus Year Ago | Net Earnings | % Change Versus Year Ago | |
|---|---|---|---|---|---|---|
| Beauty | $3,316 | 9% | $721 | 30% | $577 | 32% |
| Grooming | 1,438 | 4% | 314 | 3% | 256 | 1% |
| Health Care | 2,356 | 4% | 484 | (7)% | 377 | (8)% |
| Fabric & Home Care | 6,275 | 8% | 1,348 | 6% | 1,027 | 7% |
| Baby, Feminine & Family Care | 4,604 | —% | 1,133 | —% | 871 | 1% |
| Corporate | 120 | N/A | (123) | N/A | 141 | N/A |
| Total Company | $18,109 | 5% | $3,877 | 11% | $3,249 | 10% |
| Nine Months Ended March 31, 2021 Net Sales | % Change Versus Year Ago | Earnings/(Loss) Before Income Taxes | % Change Versus Year Ago | Net Earnings | % Change Versus Year Ago | |
|---|---|---|---|---|---|---|
| Beauty | $10,907 | 7% | $3,145 | 16% | $2,508 | 16% |
| Grooming | 4,774 | 5% | 1,277 | 4% | 1,063 | 4% |
| Health Care | 7,573 | 8% | 1,993 | 11% | 1,557 | 13% |
| Fabric & Home Care | 19,417 | 11% | 4,689 | 21% | 3,626 | 23% |
| Baby, Feminine & Family Care | 14,185 | 3% | 3,803 | 14% | 2,924 | 15% |
| Corporate | 316 | N/A | (856) | N/A | (234) | N/A |
| Total Company | $57,172 | 7% | $14,051 | 14% | $11,444 | 11% |
Beauty
Three months ended March 31, 2021 compared with three months ended March 31, 2020
Beauty net sales increased 9% to $3.3 billion during the third fiscal quarter on a 2% increase in unit volume. Higher pricing increased net sales by 2%. Favorable mix added 3% to net sales due to the disproportionate growth of the super premium SKII brand. Foreign exchange impacts increased net sales by 2%. Organic sales increased 7%. Global market share of the Beauty segment decreased 0.5 points.
- Hair Care net sales increased high single digits due to a mid-single digit increase in volumes and devaluation-related price increases. Organic sales also increased high single digits. The volume increase was driven by a more than 20% increase in Greater China (due to distribution growth and lower base period volume caused by pandemic-related shutdowns) and high single digits increase in North America (due to innovation and lower base period volume caused by pandemic-related supply constraints). Volume also increased double digits in IMEA and increased low single digits in Latin America due to innovation, partially offset by double digit decline in Europe due to category declines and devaluation related price increases in certain markets. Global market share of the Hair Care category was unchanged.
- Skin and Personal Care net sales increased double digits due to favorable mix impacts driven by the disproportionate growth of the super premium SKII brand, increased pricing and favorable foreign exchange impacts, partially offset by a mid-single digit decrease in volumes. Organic sales increased high single digits. Volume decreased mid-teens in IMEA, decreased double digits in Europe and Asia Pacific and decreased mid-single digits in North America, all primarily due to pandemic-related skin care and deodorant category declines. This was partially offset by high single digits volume growth in Greater China driven by increased consumption of personal care products due to the pandemic. Global market share of the Skin and Personal Care category decreased more than half a point.
Net earnings increased 32% to $577 million due to the increase in net sales and a 300 basis-point increase in net earnings margin. The net earnings margin increased due to a reduction in SG&A as a percentage of net sales and an increase in gross margin. The gross margin increase was driven by the positive impacts of manufacturing cost savings and increased pricing, partially offset by increased commodity costs. The decrease in SG&A as a percentage of net sales was primarily due to the positive scale impacts of the net sales increase.
Beauty fiscal year to date net sales increased 7% to $10.9 billion on a 4% increase in unit volume. Higher pricing increased net sales by 2%. Favorable mix added 1% to net sales due to the disproportionate growth of the super premium SKII brand. Foreign exchange had no net impact to net sales. Organic sales increased 6%. Global market share of the Beauty segment decreased 0.7 points.
- Hair Care net sales increased mid-single digits due to a mid-single digit increase in volumes and increased pricing, partially offset by unfavorable foreign exchange impacts. Organic sales increased high single digits. The volume increase was driven by a mid-teens increase in Greater China (due to market growth, distribution growth and to a lesser extent the low base period due to pandemic-related shutdowns) and mid-single digits increases in North America, Latin America and IMEA (due to innovation and increased demand following pandemic-related shutdowns), partially offset by a mid-single digits decrease in Europe due to pandemic-related consumption declines. Global market share of the Hair Care category was unchanged.
- Skin and Personal Care net sales increased high single digits due to a low single digit increase in volumes, favorable mix due to the disproportionate growth of the super premium SKII brand, increased pricing and favorable foreign exchange impacts. Organic sales increased mid-single digits. Volume grew double digits in Greater China and grew low single digits in North America driven by increased consumption of personal care products due to the pandemic, partially offset by double digits volume decrease in IMEA due to pandemic-related category declines. Global market share of the Skin and Personal Care category decreased less than a point.
Net earnings increased 16% to $2.5 billion due to the increase in net sales and a 170 basis-point increase in net earnings margin. The net earnings margin increased due to a reduction in SG&A as a percentage of net sales and an increase in gross margin. The gross margin increase was primarily driven by manufacturing cost savings and increased selling prices, partially offset by the negative impacts of unfavorable mix due to the disproportionate growth of hair care which has lower than segment-average gross margins. The decrease in SG&A as a percentage of net sales was primarily due to the positive scale impacts of the net sales increase.
Grooming
Three months ended March 31, 2021 compared with three months ended March 31, 2020
Grooming net sales increased 4% to $1.4 billion during the third fiscal quarter on unit volume that was unchanged. Pricing had a positive 2% impact on net sales. Favorable mix had a positive 2% impact on net sales due to the disproportionate growth of Appliances category which has higher than segment-average selling prices. Foreign exchange had no net impact to net sales. Organic sales also increased 4%. Global market share of the Grooming segment decreased 0.3 points.
- Shave Care net sales were unchanged as a low single digits volume decrease, unfavorable foreign exchange impacts and unfavorable mix impact (due to the disproportionate growth of IMEA which has lower than category-average selling prices), were offset by devaluation-related price increases. Organic sales were also unchanged. Volume decreased high single digits in Europe and Asia Pacific primarily due to pandemic-related consumption decline. This was partially offset by double digit volume growth in IMEA (due to innovation), high single digit growth in Greater China (due to market growth) and low single digit growth in North America (due to innovation and a lower base period due to pandemic-related distribution capacity limitations). Global market share of the Shave Care category was unchanged.
- Appliances net sales increased more than 30% primarily due to a high teens volume increase, favorable foreign exchange impacts, increased pricing and favorable mix due to the disproportionate growth of premium products. Organic sales increased more than 20%. Volume increased more than 20% in Europe and increased mid-teens in North America due to innovation and increased consumption of at-home grooming and styling products driven by the pandemic. Global market share of the Appliances category increased more than 3 points.
Net earnings increased 1% to $256 million due to the increase in net sales partially offset by a 60 basis-point decrease in net earnings margin. The net earnings margin decreased due to a reduction in gross margin, partially offset by a reduction in SG&A as a percentage of net sales. The gross margin reduction was driven by unfavorable foreign exchange impacts and the negative impact of unfavorable mix (due to the disproportionate growth of Appliances, which has lower than segment-average margins), partially offset by manufacturing cost savings and increased selling prices. SG&A as a percentage of net sales decreased primarily due to a reduction in overhead costs, driven by productivity savings and the positive scale impacts of the net sales increase, partially offset by an increase in marketing spending.
Grooming fiscal year to date net sales increased 5% to $4.8 billion on a 3% increase in unit volume. Foreign exchange had a negative 1% impact on net sales. Higher pricing increased net sales by 2%. Favorable mix had a 1% positive impact to net sales due to the disproportionate growth of the Appliances category, which has higher than segment-average selling prices. Organic sales also increased 5%. Global market share of the Grooming segment decreased 0.8 points.
- Shave Care net sales decreased low single digits primarily due to unfavorable foreign exchange impacts and unfavorable mix (due to the disproportionate growth of lower priced products in IMEA and Latin America), partially offset by a low single digit increase in volume and devaluation-related price increases. Organic sales were unchanged. Volume increased mid-teens in IMEA, increased mid-single digits in Greater China and Latin America and increased low single digits in North America due to product innovation and increased distribution in certain markets. This was partially offset by mid-single digit decreases in Europe and Asia Pacific primarily due to pandemic-related consumption declines. Global market share of the Shave Care category was unchanged.
- Appliances net sales increased more than 30% primarily due to a more than 20% increase in volume, favorable foreign exchange impacts, increased pricing and favorable mix due to the disproportionate growth of premium products. Organic sales increased around 30%. Volume increased in all regions led by a more than 30% increase in Europe and North America and a double digit increase in Asia Pacific due to innovation and increased consumption of at-home grooming and styling products driven by the pandemic. Global market share of the Appliances category increased more than two points.
Net earnings increased 4% to $1.1 billion due primarily to the increase in net sales. Net earnings margin was unchanged for the period as a reduction in SG&A as a percentage of net sales was offset by a reduction in gross margin. Gross margin decreased due to unfavorable foreign exchange impacts and unfavorable mix impacts (due to the disproportionate growth of the IMEA region and the Appliances category, both of which have lower than segment-average margins), partially offset by manufacturing cost savings and increased selling prices. SG&A as a percentage of net sales decreased due to productivity savings and the positive scale impacts of the net sales increase, partially offset by a favorable legal settlement in the base period.
Health Care
Three months ended March 31, 2021 compared with three months ended March 31, 2020
Health Care net sales increased 4% to $2.4 billion during the third fiscal quarter on unit volume that was unchanged. Favorable mix increased net sales by 3% due to the disproportionate growth of premium power brush. Foreign exchange had a 1% positive impact on net sales. Pricing had no net impact to net sales. Organic sales increased 3%. Global market share of the Health Care segment increased 2 points.
- Oral Care net sales increased double digits due to a low single digit increase in volume, favorable mix impacts due to the disproportionate growth of premium power brush and favorable foreign exchange impacts. Organic sales increased high single digits. The volume increase was driven by a more than 20% growth in IMEA (due to innovation), mid-teens growth in Greater China (due to innovation and a low base period volume due to pandemic-related lockdowns) and low single digits growth in North America (due to innovation and increased marketing spending). These volume increases were partially offset by a high single digits decline in Latin America (due to competitive activity and devaluation-related price increases) and a mid-single digits decline in Europe (due to pandemic-related lockdowns in the current period and higher base period volume due to pandemic-related pantry loading). Global market share of the Oral Care category increased more than half a point.
- Personal Health Care net sales decreased mid-single digits versus the prior year period due primarily to a mid-single digit decrease in volume. Favorable geographic mix marginally improved net sales due to the disproportionate decline of certain markets in IMEA which have lower than category-average selling prices. Organic sales also decreased mid-single digits. The volume decrease was driven by a high single digits decline in Europe and mid-single digits declines in North America and IMEA primarily driven by a lower than average cough, cold and flu season in the current period and higher base period volume due to pandemic-related pantry loading, partially offset by a mid-teens volume increase in Asia Pacific due to innovation and increased marketing spending. Global market share of the Personal Health Care category increased more than a point.
Net earnings decreased 8% to $377 million due to a 200 basis-point decrease in net earnings margin, partially offset by the increase in net sales. Net earnings margin decreased due to a decrease in gross margin and an increase in SG&A as a percentage of net sales. The decrease in gross margin was driven by unfavorable mix impacts (due to the disproportionate growth of the Oral care category, which has lower than segment-average margins and the decline in higher-margin respiratory products), and unfavorable foreign exchange impacts, partially offset by manufacturing cost savings. SG&A as a percentage of net sales increased primarily due to an increase in marketing spending.
Health Care fiscal year to date net sales increased 8% to $7.6 billion on a 4% increase in unit volume. Favorable mix increased net sales by 3% due to the disproportionate growth of the North America region and premium power brush and paste products, both of which have higher than segment-average selling prices. Increased pricing had a positive 1% impact to net sales. Foreign exchange had no net impact to net sales. Organic sales also increased 8%. Global market share of the Health Care segment increased 1.7 points.
- Oral Care net sales increased double digits due to a mid-single digit increase in volume and favorable mix impacts from the disproportionate growth of premium power brush and paste products. Organic sales also increased double digits. The volume increase was driven by mid-teens growth in IMEA, double digit growth in Greater China, mid-single digit growth in North America and low single digits growth in Europe driven by innovation and increased marketing spending. Global market share of the Oral Care category increased a point.
- Personal Health Care net sales increased low single digits versus the prior year period due to a low single digit increase in volume and increased pricing, partially offset by unfavorable foreign exchange impacts. Organic sales also increased low single digits. The volume increase was driven by double digits growth in Asia Pacific, high single digits growth in Latin America, mid-single digits growth in North America and low single digits growth in IMEA, driven by innovation, increased consumption of certain health care products and increased marketing spending. Global market share of the Personal Health Care category increased more than a point.
Net earnings increased 13% to $1.6 billion due to the increase in net sales and a 90 basis-point increase in net earnings margin. Net earnings margin increased primarily due to a decrease in SG&A as a percentage of net sales and a gain on a minor brand divestiture in the current period, partially offset by a decrease in gross margin. The decrease in gross margin was driven by unfavorable mix impacts (due to the disproportionate growth of the Oral Care category, which has lower than segment-average margins and the decline of higher-margin respiratory products), and unfavorable foreign exchange impacts, partially offset by manufacturing cost savings. SG&A as a percentage of net sales decreased primarily due to the positive scale benefits of the net sales increase, productivity savings and a reduction in other operating expenses due to costs related to the Merck OTC consumer healthcare acquisition in the base period, partially offset by increased marketing spending.
Fabric & Home Care
Three months ended March 31, 2021 compared with three months ended March 31, 2020
Fabric & Home Care net sales increased 8% to $6.3 billion during the third fiscal quarter on a 3% increase in unit volume. Positive mix impacts increased net sales by 2% due to the disproportionate growth of the North America region and the Home Care category, which have higher than segment-average prices. Higher pricing increased net sales by 2%. Foreign exchange had a 1% positive impact to net sales. Organic sales increased 7%. Global market share of the Fabric & Home Care segment increased 0.7 points.
- Fabric Care net sales increased mid-single digits due to a low single digit increase in volume, devaluation-related price increases, favorable foreign exchange impacts and positive mix impact due to the disproportionate growth of premium products and the North America region, both of which have higher than category-average selling prices. Organic sales increased low single digits. Increased volume was driven by more than 20% growth in Greater China (due to innovation and a lower base period due to pandemic-related lockdowns) and mid-single digits growth in North America (due to innovation and increased marketing spending), partially offset by a mid-single digits decline in Europe due to pandemic-related market contraction. Global market share of the Fabric Care category increased more than a point.
- Home Care net sales increased high teens, primarily due to a double digit increase in volume, increased pricing, a positive mix impact due to the disproportionate growth of premium products and the North America region, both of which have higher than category-average selling prices and favorable foreign exchange impact. Organic sales also increased high teens. The volume increase was primarily driven by mid-teens growth in North America and high single digits growth in Europe due to consumption increases related to the COVID-19 pandemic, product innovation and increased marketing spending. Global market share of the Home Care category increased more than half a point.
Net earnings increased 7% to $1.0 billion primarily due to the increase in net sales. Net earnings margin was unchanged as an increase in gross margin was offset by an increase in SG&A as a percentage of sales. The gross margin increase was driven by increased selling prices and manufacturing cost savings, partially offset by unfavorable mix impacts due to the disproportionate growth of products with lower than segment-average margins, unfavorable foreign exchange impacts and an increase in commodity costs. SG&A as a percentage of net sales increased primarily due to an increase in marketing spending, partially offset by the positive scale benefits of the net sales increase.
Fabric & Home Care fiscal year to date net sales increased 11% to $19.4 billion on a 7% increase in unit volume. Positive mix impacts increased net sales by 3% due to the disproportionate growth of the North America region and the Home Care category, both of which have higher than segment-average prices. Higher pricing increased net sales by 1%. Foreign exchange had no net impact to net sales. Organic sales also increased 11%. Global market share of the Fabric & Home Care segment increased 0.9 points.
- Fabric Care net sales increased high single digits due to a mid-single digit increase in volume, positive mix impact due to the disproportionate growth of premium products and the North America region and increased pricing. Organic sales increased mid-single digits. Increased volume was driven by double digit growth in North America and Greater China due to product innovation, incremental marketing spending and consumption increases related to the COVID-19 pandemic. These volume increases were partially offset by a low single digits decline in Europe and Asia Pacific due to market contraction and competitive activities. Global market share of the Fabric Care category increased more than a point.
- Home Care net sales increased more than 20% primarily due to a volume increase of around 20%, positive mix impact due to the disproportionate growth of premium products and the North America region, both of which have higher than segment-average prices, and increased pricing. Organic sales also increased more than 20%. Volume increased in all regions led by more than 20% growth in North America, high teens growth in Latin America, mid-teens growth in Europe, and high single digits growth in Asia Pacific (all due to consumption increases related to the COVID-19 pandemic), product innovation and incremental marketing spending. Global market share of the Home Care category increased more than half a point.
Net earnings increased 23% to $3.6 billion due to the increase in net sales and a 170 basis-point increase in net earnings margin. The net earnings margin increase was due to an increase in gross margin and a marginal decrease in SG&A as a percentage of sales. The gross margin increase was driven by manufacturing cost savings, increased selling prices and a reduction in commodity costs, partially offset by unfavorable foreign exchange impacts and unfavorable mix due to the disproportionate growth of products with lower than segment-average margins. SG&A as a percentage of net sales decreased primarily due to the positive scale benefits of the net sales increase, partially offset by an increase in marketing spending.
Baby, Feminine & Family Care
Three months ended March 31, 2021 compared with three months ended March 31, 2020
Baby, Feminine & Family Care net sales were unchanged at $4.6 billion during the third fiscal quarter on a 4% decrease in unit volume. Higher pricing increased net sales by 2%. Favorable mix had a 1% positive impact to net sales due to the disproportionate growth of premium products, including diaper pants and adult incontinence. Foreign exchange had a 1% positive impact to net sales. Organic sales decreased 1%. Global market share of the Baby, Feminine & Family Care segment decreased 0.6 points.
- Net sales in Baby Care decreased mid-single digits due to a high single digit decrease in volume, partially offset by favorable foreign exchange impact and positive mix impact due to the relatively lower decline of the North America region and the growth of premium products. Organic sales also decreased mid-single digits. Volume decreased mid-teens in Asia Pacific (due to competitive activity and category contraction in certain markets), decreased double digits in Greater China (due to competitive activity) and Europe (due to reduction in retailer inventories, competitive activity in certain markets and higher base period volume due to pandemic-related pantry loading), and decreased mid-single digits in North America (primarily due to higher base period volume due to pandemic-related pantry loading). Global market share of the Baby Care category decreased nearly half a point.
- Feminine Care net sales were unchanged as a mid-single digit volume decline was offset by a positive mix impact driven by the growth of the North America region and premium products and favorable foreign exchange impact. Organic sales decreased low single digits. Volume decreased high-teens in Europe (due to pandemic-related market declines in the current period and higher base period volume due to pandemic-related pantry loading) and decreased mid-single digits in Latin America (due to pandemic-related consumption declines and competitive activity). This was partially offset by a mid-single digits volume increase in Greater China and a low single digits increase in North America and IMEA, primarily due to innovation. Global market share of the Feminine Care category increased more than half a point.
- Net sales in Family Care, which is predominantly a North American business, increased mid-single digits primarily due to increased pricing (driven by lower consumer promotions). Volume was unchanged. Organic sales also increased mid-single digits. North America share of the Family Care category decreased more than two points.
Net earnings increased 1% to $871 million primarily due to a 20 basis-point increase in net earnings margin. Net earnings margin increased primarily due to an increase in gross margin, offset by an increase in SG&A as a percentage of net sales. Gross margin increased primarily due to higher selling prices, partially offset by unfavorable foreign exchange impacts and an increase in commodity costs. SG&A as a percentage of net sales increased primarily due to an increase in overhead costs.
Baby, Feminine & Family Care fiscal year to date net sales increased 3% to $14.2 billion on a 1% increase in unit volume. Higher pricing increased net sales by 1%. Favorable mix impact increased net sales by 1% due to the disproportionate growth of the North America region. Foreign exchange had no net impact to net sales. Organic sales also increased 3%. Global market share of the Baby, Feminine & Family Care segment decreased 0.4 points.
- Net sales in Baby Care decreased low single digits due to a mid-single digit decrease in volume, partially offset by devaluation-related price increases and positive mix impact due to the growth of the North America region and premium
products. Organic sales also decreased low single digits. Volume decreased double digits in Greater China (due to competitive activity and consumer pantry destocking), decreased high single digits in Latin America (due to market contraction), IMEA (due to pandemic-related retailer inventory reductions and market contraction), and Asia Pacific (due primarily to market contractions and competitive activity) and decreased mid-single digits in Europe (due to market contractions and competitive activity in certain markets). These volume decreases were partially offset by low single digits volume growth in North America due to consumption increase in certain products and innovation. Global market share of the Baby Care category decreased more than half a point.
- Feminine Care net sales increased mid-single digits due to increased pricing and positive mix impact of the growth of the North America region and premium products. This was partially offset by a low single digit decrease in global volume. Organic sales also increased mid-single digits. Volume decreased high single digits in Europe (due to pandemic-related consumption declines) and decreased mid-single digits in Latin America (due to competitive activity and pandemic-related consumption declines). Volume increased mid-single digits in North America (due to innovation) and in IMEA (primarily due to market growth and innovation). Global market share of the Feminine Care category increased less than a point.
- Net sales in Family Care, which is predominantly a North American business, increased double digits driven by a high single digit increase in volumes and increased pricing driven by lower consumer promotions, partially offset by unfavorable mix impact due to the disproportionate growth of larger pack sizes. Organic sales also increased double digits. The volume increase was driven by a pandemic-related consumption increase and pantry loading, and to a lesser extent, retailer inventory restocking. North America share of the Family Care category decreased more than a point.
Net earnings increased 15% to $2.9 billion due to the increase in net sales and a 200 basis-point increase in net earnings margin. Net earnings margin increased primarily due to an increase in gross margin, and to a lesser extent, a decrease in SG&A as a percentage of net sales. Gross margin increased due to manufacturing cost savings, increased selling prices and a reduction in commodity costs, partially offset by unfavorable foreign exchange impacts. SG&A as a percentage of net sales decreased primarily due to the positive scale benefits of the net sales increase.
Corporate
Corporate includes certain operating and non-operating activities not allocated to specific business segments. These include: the incidental businesses managed at the corporate level; financing and investing activities; certain employee benefit costs; other general corporate items; the gains and losses related to certain divested brands and categories; and certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Corporate also includes reconciling items to adjust the accounting policies used in the reportable segments to U.S. GAAP. The most significant reconciling item relates to income taxes, to adjust from blended statutory rates that are reflected in the reportable segments to the overall Company effective tax rate.
Corporate net sales improved by $4 million to $120 million for the quarter ended March 31, 2021 and increased $10 million to $316 million for the fiscal year to date. Corporate net earnings improved by $98 million in the quarter due to lower restructuring charges versus the base period and the current period unrealized gain on an equity investment that became publicly traded in the quarter, partially offset by a higher current period tax rate all of which have been described above. Corporate net earnings decreased $473 million for the fiscal year to date period, primarily due to the $427 million ($512 million before tax) current period charge for early debt extinguishment, higher interest expense, lower interest income, and the higher current year tax rate, partially offset by lower restructuring charges versus the base period and the current period unrealized gain from an equity investment, all of which have been described above.
Restructuring Program to deliver Productivity and Cost Savings
In 2012, the Company initiated a productivity and cost savings plan to reduce costs and better leverage scale in the areas of supply chain, research and development, marketing and overheads. The plan was designed to accelerate cost reductions by streamlining management decision making, manufacturing and other work processes to fund the Company's growth strategy. In 2017, the Company communicated specific elements of an additional multi-year productivity and cost savings program. As part of this plan, which was largely completed by the end of fiscal 2020, the Company incurred $1.5 billion in total before-tax restructuring costs across fiscal 2019 and fiscal 2020.
In fiscal 2021 and onwards, the Company expects to incur restructuring costs within the range of our historical ongoing level of $250 to $500 million before tax. In addition to our restructuring programs, we have additional ongoing savings efforts in our supply chain, marketing and overhead areas that have and are expected to continue to yield additional benefits to our operating margins.
Refer to Note 9 in the Notes to the Consolidated Financial Statements for more details on the restructuring program.
LIQUIDITY & CAPITAL RESOURCES
Operating Activities
We generated $14.3 billion of cash from operating activities fiscal year to date, an increase of $1.7 billion versus the prior year period. Net earnings, adjusted for non-cash items (depreciation and amortization, loss on extinguishment of debt, share-based compensation expense, deferred income taxes and gain on sale of assets), generated $14.2 billion of operating cash flow. Working capital and other impacts generated $53 million of cash in the period. Accounts receivable increased, using $604 million of cash, primarily due to sales growth. Days sales outstanding also increased about two days driven by higher relative amount of sales towards the end of the quarter. Inventory increased, consuming $399 million of cash primarily due to business growth, increased safety stock levels during the COVID-19 pandemic and commodity cost increases. Accounts payable, accrued and other liabilities increased, generating $1.0 billion of cash. About half of this increase was driven by extended payment terms to suppliers. The remaining increase is due to higher marketing spending and to support the increase in inventory. These increases were partially offset by the payment of prior fiscal year-end incentive compensation and other salary-related accruals.
Investing Activities
Investing activities used $2.0 billion of cash fiscal year to date primarily due to capital expenditures.
Financing Activities
Financing activities used $18.4 billion of cash fiscal year to date. We used $8.0 billion for treasury stock purchases and $6.1 billion for dividends. We used $5.8 billion for net debt reductions, including $512 million for early debt extinguishment costs related to the early retirement of $2.3 billion of debt. The exercise of stock options and other financing activities generated $1.5 billion of cash.
As of March 31, 2021, our current liabilities exceeded current assets by $9.4 billion. We have short- and long-term debt to meet our financing needs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings that have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements.
RECONCILIATION OF MEASURES NOT DEFINED BY U.S. GAAP
In accordance with the SEC's Regulation S-K Item 10(e), the following provides definitions of the non-GAAP measures and the reconciliation to the most closely related GAAP measures. We believe that these measures provide useful perspective on underlying business results and trends (i.e., trends excluding non-recurring or unusual items) and provide a supplemental measure of year-on-year results. The non-GAAP measures described below are used by management in making operating decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors as they provide supplemental information about business performance and provide investors a view of our business results through the eyes of management. These measures are also used to evaluate senior management and are a factor in determining their at-risk compensation. These non-GAAP measures are not intended to be considered by the user in place of the related GAAP measures, but rather as supplemental information to our business results. These non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in method and in the items or events being adjusted.
Organic sales growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions and divestitures and foreign exchange from year-over-year comparisons. We believe this measure provides investors with a supplemental understanding of underlying sales trends by providing sales growth on a consistent basis. This measure is used in assessing achievement of management goals for at-risk compensation.
Adjusted free cash flow: Adjusted free cash flow is defined as operating cash flow less capital spending and excluding payments for the transitional tax resulting from the U.S. Tax Act (the company incurred a transitional tax liability of approximately $3.8 billion in fiscal 2018 from the U.S. Tax Act of 2017 which is payable over a period of 8 years). Adjusted free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion. Management views adjusted free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investments.
Adjusted free cash flow productivity: Adjusted free cash flow productivity is defined as the ratio of adjusted free cash flow to net earnings excluding the charges for early debt extinguishment (which are not considered part of our ongoing operations). Management views adjusted free cash flow productivity as a useful measure to help investors understand P&G’s ability to generate cash. Adjusted free cash flow productivity is used by management in making operating decisions, allocating financial resources and for budget planning purposes. This measure is also used in assessing the achievement of management goals for at-risk compensation. The Company's long-term target is to generate annual adjusted free cash flow productivity at or above 90 percent.
Core EPS: Core earnings per share, or Core EPS, is a measure of the Company's diluted net earnings per share adjusted as indicated. Management views this non-GAAP measure as a useful supplemental measure of Company performance over time. This measure is also used when evaluating senior management in determining their at-risk compensation.
The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following items:
Incremental Restructuring: The Company has historically had an ongoing level of restructuring activities. Such activities have resulted in ongoing annual restructuring-related charges of approximately $250 - $500 million before tax. Beginning in 2012, the Company has had a strategic productivity and cost savings initiative that resulted in incremental restructuring charges. The adjustment to Core earnings includes only the restructuring costs above what we believe are the normal recurring level of restructuring costs. In fiscal 2021 and onwards, the Company expects to incur restructuring costs within our historical ongoing level noted above.
Early debt extinguishment charges: In the three months ended December 31, 2020, the Company recorded after tax charges of $427 million ($512 million before tax), due to early extinguishment of certain long-term debt. These charges represent the difference between the reacquisition price and the par value of the debt extinguished.
We do not view the above items to be part of our sustainable results and their exclusion from Core earnings measures provides a more comparable measure of year-over-year results. These items are also excluded when evaluating senior management in determining their at-risk compensation.
Organic sales growth:
| Three Months Ended March 31, 2021 | Net Sales Growth | Foreign Exchange Impact | Acquisition & Divestiture Impact/Other (1) | Organic Sales Growth |
|---|---|---|---|---|
| Beauty | 9% | (2)% | —% | 7% |
| Grooming | 4% | —% | —% | 4% |
| Health Care | 4% | (1)% | —% | 3% |
| Fabric & Home Care | 8% | (1)% | —% | 7% |
| Baby, Feminine & Family Care | —% | (1)% | —% | (1)% |
| Total Company | 5% | (1)% | —% | 4% |
(1) Acquisitions/Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.
| Nine Months Ended March 31, 2021 | Net Sales Growth | Foreign Exchange | Acquisition & Divestiture Impact/Other (1) | Organic Sales Growth |
|---|---|---|---|---|
| Beauty | 7% | —% | (1)% | 6% |
| Grooming | 5% | 1% | (1)% | 5% |
| Health Care | 8% | —% | —% | 8% |
| Fabric & Home Care | 11% | —% | —% | 11% |
| Baby, Feminine & Family Care | 3% | —% | —% | 3% |
| Total Company | 7% | —% | —% | 7% |
(1) Acquisitions/Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.
Adjusted free cash flow (dollar amounts in millions):
Nine Months Ended March 31, 2021
| Operating Cash Flow | Capital Spending | U.S. Tax Act Payments | Adjusted Free Cash Flow |
|---|---|---|---|
| $14,250 | $(2,073) | $225 | $12,402 |
Adjusted free cash flow productivity (dollar amounts in millions):
Nine Months Ended March 31, 2021
| Adjusted Free Cash Flow | Net Earnings | Early Debt Extinguishment Charges | Net Earnings Excluding Adjustments | Adjusted Free Cash Flow Productivity |
|---|---|---|---|---|
| $12,402 | $11,444 | $427 | $11,871 | 104% |
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures
| Three Months Ended March 31, 2021 AS REPORTED (GAAP) | Three Months Ended March 31, 2020 AS REPORTED (GAAP) | INCREMENTAL RESTRUCTURING | NON-GAAP (CORE) | |
|---|---|---|---|---|
| NET EARNINGS ATTRIBUTABLE TO P&G | 3,269 | 2,917 | 141 | 3,058 |
| Core EPS | ||||
| DILUTED NET EARNINGS PER COMMON SHARE (1) | $1.26 | $1.12 | $0.05 | $1.17 |
(1) Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
| CHANGE IN CURRENT YEAR REPORTED (GAAP) MEASURES VERSUS PRIOR YEAR NON-GAAP (CORE) MEASURES (1) | |
|---|---|
| NET EARNINGS ATTRIBUTABLE TO P&G | 7% |
| EPS | 8% |
(1) Change versus year ago is calculated based on As Reported (GAAP) values for the three months ended March 31, 2021 versus the Non-GAAP (Core) values for the three months ended March 31, 2020.
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures
| Nine Months Ended March 31, 2021 AS REPORTED (GAAP) | EARLY DEBT EXTINGUISHMENT | NON-GAAP (CORE) | Nine Months Ended March 31, 2020 AS REPORTED (GAAP) | INCREMENTAL RESTRUCTURING | NON-GAAP (CORE) | |
|---|---|---|---|---|---|---|
| NET EARNINGS ATTRIBUTABLE TO P&G | 11,400 | 427 | 11,827 | 10,227 | 189 | 10,416 |
| Core EPS | ||||||
| DILUTED NET EARNINGS PER COMMON SHARE (1) | $4.37 | $0.16 | $4.53 | $3.89 | $0.07 | $3.96 |
(1) Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
| CHANGE VERSUS YEAR AGO | |
|---|---|
| CORE NET EARNINGS ATTRIBUTABLE TO P&G | 14% |
| CORE EPS | 14% |
Market risk
As filed, 242 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes in the Company’s exposure to market risk since June 30, 2020. Additional information can be found in Note 7 - Risk Management Activities and Fair Value Measurements of the Consolidated Financial Statements.
Controls and procedures
As filed, 1,282 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
The Company’s Chairman of the Board, President and Chief Executive Officer, David S. Taylor, and the Company’s Chief Financial Officer, Andre Schulten, performed an evaluation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (“Exchange Act”)) as of the end of the period covered by this report. Messrs. Taylor and Schulten have concluded that the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. Taylor and Schulten, to allow their timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the Company’s fiscal quarter ended March 31, 2021 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Risk factors
As filed, 145 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
For information on risk factors, please refer to "Risk Factors" in Part I, Item 1A of the Company's Form 10-K/A for the year ended June 30, 2020.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-01-01 to 2021-03-31 | $18.11bn | us-gaap:Revenues |
| Revenue | 9 months2020-07-01 to 2021-03-31 | $57.17bn | us-gaap:Revenues |
| Cost of revenue | 3 months2021-01-01 to 2021-03-31 | $8.92bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2020-07-01 to 2021-03-31 | $27.32bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2021-01-01 to 2021-03-31 | $5.40bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-07-01 to 2021-03-31 | $15.41bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-01-01 to 2021-03-31 | $3.79bn | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-07-01 to 2021-03-31 | $14.45bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-01-01 to 2021-03-31 | $106.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2020-07-01 to 2021-03-31 | $385.0m | us-gaap:InterestExpense |
| Income tax | 3 months2021-01-01 to 2021-03-31 | $628.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-07-01 to 2021-03-31 | $2.61bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-01-01 to 2021-03-31 | $3.27bn | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-07-01 to 2021-03-31 | $11.40bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-01-01 to 2021-03-31 | $1.26 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-07-01 to 2021-03-31 | $4.37 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-01-01 to 2021-03-31 | $1.30 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-07-01 to 2021-03-31 | $4.53 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-01-01 to 2021-03-31 | 2,590,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-07-01 to 2021-03-31 | 2,610,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-07-01 to 2021-03-31 | $14.25bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-07-01 to 2021-03-31 | $2.07bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2020-07-01 to 2021-03-31 | $6.07bn | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2020-07-01 to 2021-03-31 | $8.01bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2021-03-31 | $22.61bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-03-31 | $116.78bn | us-gaap:Assets |
| Current liabilities | At period end2021-03-31 | $32.02bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-03-31 | $69.86bn | us-gaap:Liabilities |
| Long-term debt | At period end2021-03-31 | $21.05bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2021-03-31 | $8.77bn | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2021-03-31 | $46.92bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
| Shares outstanding | At period end2021-03-31 | 2,448,232,786 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000080424-21-000062. Last ingested by Listed: Nov 13, 2026, 16:40 ET. Listed shows no prices and gives no investment advice.